Asthma management chart for children 0-4 years of age.
In patients with eosinophilic asthma, treatment with intravenous reslizumab is associated with improved clinical and patient-reported outcomes.
Expert artificial intelligence-based natural language processing algorithms may help clinicians and researchers systematically identify childhood asthma and its subgroups with distinctive characteristics from electronic health records.
Late-diagnosed asthma was identified as the most independent significant risk factor for non-remission in patients with asthma.
Reference equations to predict forced expiratory flow values adjusted for forced vital capacity resulted in lower sample variability.
The National Asthma Education and Prevention Program published focused updates to their asthma management guidelines.